Page last updated: 2024-09-02

landiolol and Disease, Pulmonary

landiolol has been researched along with Disease, Pulmonary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ibe, T; Kamiyoshihara, M; Kawashima, O; Nagashima, T; Nakano, T; Shimizu, K; Takeyoshi, I1

Other Studies

1 other study(ies) available for landiolol and Disease, Pulmonary

ArticleYear
Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
    Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:4

    Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Female; Heart Rate; Humans; Infusions, Intravenous; Lung Diseases; Male; Middle Aged; Morpholines; Retrospective Studies; Secondary Prevention; Tachycardia, Supraventricular; Treatment Outcome; Urea

2012